Cardinal Health Inc (NYSE:CAH) – Stock analysts at Jefferies Group issued their FY2017 earnings per share estimates for shares of Cardinal Health in a report released on Wednesday. Jefferies Group analyst B. Tanquilut anticipates that the company will earn $5.36 per share for the year. Jefferies Group has a “Hold” rating and a $77.00 price objective on the stock. Jefferies Group also issued estimates for Cardinal Health’s Q4 2017 earnings at $1.26 EPS, Q1 2018 earnings at $1.18 EPS, Q2 2018 earnings at $1.34 EPS, Q3 2018 earnings at $1.41 EPS, Q4 2018 earnings at $1.30 EPS and FY2018 earnings at $5.23 EPS.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Monday, May 1st. The company reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.46 by $0.07. Cardinal Health had a return on equity of 25.52% and a net margin of 1.06%. The company had revenue of $31.82 billion during the quarter, compared to analysts’ expectations of $32.30 billion. During the same period in the prior year, the company earned $1.43 EPS. Cardinal Health’s revenue was up 3.8% compared to the same quarter last year.

TRADEMARK VIOLATION NOTICE: This report was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/05/18/brokers-issue-forecasts-for-cardinal-health-incs-fy2017-earnings-cah.html.

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Several other analysts also recently weighed in on CAH. Zacks Investment Research downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating in a research note on Friday, February 10th. Needham & Company LLC assumed coverage on shares of Cardinal Health in a research note on Tuesday, April 4th. They issued a “hold” rating for the company. Evercore ISI boosted their price target on shares of Cardinal Health from $77.50 to $78.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 2nd. Credit Suisse Group AG reissued a “buy” rating and issued a $81.00 price target on shares of Cardinal Health in a research note on Tuesday, May 2nd. Finally, Barclays PLC reissued an “overweight” rating and issued a $82.00 price target (down from $88.00) on shares of Cardinal Health in a research note on Saturday, April 22nd. Two equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and five have assigned a buy rating to the stock. Cardinal Health has an average rating of “Hold” and an average price target of $82.71.

Cardinal Health (NYSE:CAH) traded up 0.89% during mid-day trading on Thursday, reaching $72.24. The company had a trading volume of 462,986 shares. Cardinal Health has a 12-month low of $62.70 and a 12-month high of $85.52. The firm has a market capitalization of $22.82 billion, a price-to-earnings ratio of 17.25 and a beta of 0.71. The firm has a 50-day moving average price of $75.93 and a 200 day moving average price of $75.51.

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, July 15th. Stockholders of record on Monday, July 3rd will be paid a dividend of $0.4624 per share. This represents a $1.85 annualized dividend and a dividend yield of 2.58%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.45. The ex-dividend date is Thursday, June 29th. Cardinal Health’s dividend payout ratio is 43.17%.

In other news, CEO Jon L. Giacomin sold 23,270 shares of the company’s stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $72.87, for a total transaction of $1,695,684.90. Following the completion of the transaction, the chief executive officer now directly owns 55,440 shares of the company’s stock, valued at $4,039,912.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.94% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Massmutual Trust Co. FSB ADV bought a new position in shares of Cardinal Health during the fourth quarter valued at about $101,000. Advisory Services Network LLC bought a new position in shares of Cardinal Health during the first quarter valued at about $120,000. SRB Corp boosted its position in shares of Cardinal Health by 4.6% in the third quarter. SRB Corp now owns 1,914 shares of the company’s stock valued at $149,000 after buying an additional 84 shares in the last quarter. Quadrant Capital Group LLC boosted its position in shares of Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock valued at $156,000 after buying an additional 116 shares in the last quarter. Finally, Northwest Quadrant Wealth Management LLC bought a new position in shares of Cardinal Health during the fourth quarter valued at about $173,000. Institutional investors own 85.84% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

5 Day Chart for NYSE:CAH

Receive News & Ratings for Cardinal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.